 |
|
Survival rates exceed national averages for UCSF heart, liver and lung transplant programs
March 03, 2008One-year survival rates for patients receiving heart, liver and lung transplants at UCSF Medical Center exceed national averages at statistically significant levels, according to new data compiled by the Scientific Registry of Transplant Recipients (SRTR).
Released on January 11, the report measures performance and characteristics of each transplant program at all facilities in the United States, including waiting list outcomes, post-transplant survival rates, and organ recovery and transplantation rates. Reported statistics can be found on the SRTR website (http://www.ustransplant.org).
"The registry collects data from the nation's transplant programs and uses an algorithm they created to standardize calculations across facilities, looking at such information as how sick patients are in each program and then assigning an expected survival rate," explained John P. Roberts, MD, chief of the UCSF Medical Center Transplant Service.
According to the report, the one-year survival rate for the UCSF Heart Transplant Program was 100 percent, compared to an expected survival rate of 87 percent. The UCSF Liver Transplant Program produced a one-year survival rate of 92 percent compared to an expected 88 percent, and the Lung Transplant Program generated a one-year survival rate of 90 percent compared to an expected 80 percent. The expected survival rates reflect the health condition of each program's transplant patients.
UCSF is recognized for tackling the most complex transplant surgeries, including multiple organ transplants, and is the only hospital among the U.S. News & World Report top 18 hospitals with these three programs that exceeds the national averages for expected survival rates at significant levels.
UCSF transplant teams include a full range of patient care and support personnel, and all are committed to achieving better-than-expected survival rates, according to Roberts and also emphasized by Teresa De Marco, MD, medical director of the UCSF Heart Transplant Program.
Many audiences, such as patients and families looking to select a transplant program, use the SRTR data. Transplant surgeons use it to explain a patient's prospects for recovery, as do administrators addressing quality control for transplant programs, insurance companies and payers, and federal regulatory bodies charged with protecting patients.
Transplants are the most advanced treatment for patients with severe, end-stage disease with no other effective, available medical or surgical treatments, according to clinicians.
The Heart Transplant Program at UCSF began in 1989 and is expected to soon perform its 500th procedure. The program focuses on pulmonary hypertension and right ventricular failure, combined heart-kidney transplant, transplant for Chagas disease, transplant for congenital heart disease, transplant for HIV, and research on the genomics of heart failure and allograft loss (rejection of donor organ).
Since it began in 1988, the Liver Transplant Program has performed more than 2,100 liver transplants for adults and children. The program is designated as a Center of Excellence by the U.S. Department of Health and Human Services and performs more liver transplants than any other hospital in Northern California. Program specialists are currently conducting research in the areas of living donor transplantation, liver cancer, clinical therapeutics in liver transplantation, transplantation in HIV-infected patients, hepatitis C antiviral therapy, and recurrent viral disease.
The UCSF Lung Transplant Program has performed more than 250 transplants since the program began in 1991, and it is a specialized center of excellence for treating cystic fibrosis and pulmonary hypertension. The program also focuses on ECMO (extracorporeal membrane oxygenation) as a bridge to transplant for acute respiratory failure, the role of transplant in malignancy (bronchoalveolar carcinoma), and transplant for HIV patients. Current research includes the genomics of transplant rejection, acute lung injury and fungal infections.
Information about all of UCSF's transplant programs can be found at: http://www.ucsfhealth.org/adult/medical_services/ organ_transplants/.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
The University of California, San Francisco
According to the report, the one-year survival rate for the UCSF Heart Transplant Program was 100 percent, compared to an expected survival rate of 87 percent. The UCSF Liver Transplant Program produced a one-year survival rate of 92 percent compared to an expected 88 percent, and the Lung Transplant Program generated a one-year survival rate of 90 percent compared to an expected 80 percent. The expected survival rates reflect the health condition of each program's transplant patients.
UCSF is recognized for tackling the most complex transplant surgeries, including multiple organ transplants, and is the only hospital among the U.S. News & World Report top 18 hospitals with these three programs that exceeds the national averages for expected survival rates at significant levels.
UCSF transplant teams include a full range of patient care and support personnel, and all are committed to achieving better-than-expected survival rates, according to Roberts and also emphasized by Teresa De Marco, MD, medical director of the UCSF Heart Transplant Program.
Many audiences, such as patients and families looking to select a transplant program, use the SRTR data. Transplant surgeons use it to explain a patient's prospects for recovery, as do administrators addressing quality control for transplant programs, insurance companies and payers, and federal regulatory bodies charged with protecting patients.
Transplants are the most advanced treatment for patients with severe, end-stage disease with no other effective, available medical or surgical treatments, according to clinicians.
The Heart Transplant Program at UCSF began in 1989 and is expected to soon perform its 500th procedure. The program focuses on pulmonary hypertension and right ventricular failure, combined heart-kidney transplant, transplant for Chagas disease, transplant for congenital heart disease, transplant for HIV, and research on the genomics of heart failure and allograft loss (rejection of donor organ).
Since it began in 1988, the Liver Transplant Program has performed more than 2,100 liver transplants for adults and children. The program is designated as a Center of Excellence by the U.S. Department of Health and Human Services and performs more liver transplants than any other hospital in Northern California. Program specialists are currently conducting research in the areas of living donor transplantation, liver cancer, clinical therapeutics in liver transplantation, transplantation in HIV-infected patients, hepatitis C antiviral therapy, and recurrent viral disease.
The UCSF Lung Transplant Program has performed more than 250 transplants since the program began in 1991, and it is a specialized center of excellence for treating cystic fibrosis and pulmonary hypertension. The program also focuses on ECMO (extracorporeal membrane oxygenation) as a bridge to transplant for acute respiratory failure, the role of transplant in malignancy (bronchoalveolar carcinoma), and transplant for HIV patients. Current research includes the genomics of transplant rejection, acute lung injury and fungal infections.
Information about all of UCSF's transplant programs can be found at: http://www.ucsfhealth.org/adult/medical_services/ organ_transplants/.
UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
The University of California, San Francisco
Transplant Current Events and Transplant News RSSHigh Blood Pressure Easy to Miss in Children with Kidney Disease
Spot blood pressure readings in children with chronic kidney disease often fail to detect hypertension - even during doctor's office visits - increasing a child's risk for serious heart problems, according to research from Johns Hopkins Children's Center and other institutions. A report of the findings appears online in the Journal of American Society of Nephrology.
Gene mismatch influences success of bone marrow transplants
A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics.
Your Own Stem Cells Can Treat Heart Disease
The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells.
U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning.
Young athletes need dual screening tests for heart defects, study suggests
To best detect early signs of life-threatening heart defects in young athletes, screening programs should include both popular diagnostic tests, not just one of them, according to new research from heart experts at Johns Hopkins.
Texas Children's discharges first pediatric patient with implanted mechanical heart device
Texas Children's Hospital is the nation's first pediatric hospital to discharge a child while on an intracorporeal ventricular assist device (VAD), a feat previously accomplished only at adult institutions.
Scientists successfully reprogram blood cells
Researchers have transplanted genetically modified hematopoietic stem cells into mice so that their developing red blood cells produce a critical lysosomal enzyme -preventing or reducing organ and central nervous system damage from the often-fatal genetic disorder Hurler's syndrome.
UCI embryonic stem cell therapy restores walking ability in rats with neck injuries
The first human embryonic stem cell treatment approved by the FDA for human testing has been shown to restore limb function in rats with neck spinal cord injuries - a finding that could expand the clinical trial to include people with cervical damage.
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
Gastroenterology/hepatology societies release report evaluating fellowship training curriculum
Due to the increasing complexities of treating digestive diseases, allowing gastroenterological (GI) trainee physicians the opportunity to develop enhanced abilities and experiences in specific disease areas or procedures will be a great benefit to patients, according to a "Report of the Multisociety Task Force on GI Training."
More Transplant Current Events and Transplant News Articles
 |
Transplants by Transplants From January 2000 to June 2002, Rancid frontman Tim Armstrong laboriously pored over loops and samples, collecting synth squeals and snatches of howling guitar and, naturally, writing songs. Aided by raging rapper Rob Aston, he's put it all together to form this often intriguing and strangely beguiling side project. The opening's not promising. With the death-riff of "Romper Stomper" followed by the urban R&B and chanted party-rock chorus of "Tall Cans in the Air," Armstrong flails badly. But then his Clash obsession kicks in once more. This London-Kingston-California hybrid is thoroughly weird but oddly touching. It rings out in "Weigh on My Mind" and "Diamonds and Guns," with its Sex Pistols-inspired marching intro, rollicking piano, and Stones-like woo-woos, while the closing "Down in... |
 |
Transplant by John A. Elefteriades (Author) This book is a techno thriller. A top heart surgeon is kidnapped, seduced, threatened with an unspeakable loss -- all to make him perform a forbidden procedure. This book features cutting-edge technology. |
 |
Haunted Cities by Transplants "A few years ago, when Tim, Travis and myself were finishing up the first Transplants album, we weren't sure what was going to happen. You wouldn't believe how many people told us that they "don't get it" or that they're "not sure what people will think". To tell you the truth, we didn't really care. But here we are, a few years later, with a new Transplants album-Haunted Cities. I've always had a hard time describing our records, being as though all 3 of us have different backgrounds all 3 of us live different lives, but what I can tell you is that Haunted Cities is unlike anything else. With guest appearances by the Boo-Yaa Tribe, Rakaa from Dilated Peoples, B-Real and Sen Dog from Cypress Hill, people ain't gonna know what hit 'em. And to tell you the truth, we still don't care."-Rob... |
 |
Core Curriculum for Transplant Nurses (Critical Care Nursing ( Clochesy)) by ITNS (Author) Endorsed by the International Transplant Nurses Association, this book provides a guide to safe and effective care for solid organ transplant recipients. It includes coverage of the unique requirements of each organ transplanted, with separate chapters for heart, lung, kidney, liver, small intestine, and pancreas/islet cell transplantation. Other chapters cover important topics that affect all organs, such as immunology, infections, pharmaceutical agents, and patient education and discharge planning. Ideal as a review and study guide for the solid organ transplantation certification exam.Provides self-assessment questions at the end of each chapter.Discusses organ-specific evaluations for patients referred for transplantation.Identifies key physical findings of infection,... |
 |
Clinical Management of the Transplant Patient by Paul C. Kuo (Editor), Rebecca A. Schroeder (Editor), Lynt B. Johnson (Editor) This book provides a comprehensive overview of solid organ transplantation for residents, fellows and other personnel working in Transplant Units. It addresses the clinical management of the transplant patient from pre-transplant evaluation through surgery to outpatient follow-up. Emphasis is given to the information required for day to day management. This information is presented in a concise and practical format for easy access. |
 |
Haunted Cities by Transplants "A few years ago, when Tim, Travis and myself were finishing up the first Transplants album, we weren't sure what was going to happen. You wouldn't believe how many people told us that they "don't get it" or that they're "not sure what people will think". To tell you the truth, we didn't really care. But here we are, a few years later, with a new Transplants album-Haunted Cities. I've always had a hard time describing our records, being as though all 3 of us have different backgrounds all 3 of us live different lives, but what I can tell you is that Haunted Cities is unlike anything else. With guest appearances by the Boo-Yaa Tribe, Rakaa from Dilated Peoples, B-Real and Sen Dog from Cypress Hill, people ain't gonna know what hit 'em. And to tell you the truth, we still don't care."-Rob... |
 |
Diamonds And Guns (Album Version) Transplants (Primary Contributor) |
 |
The Puzzle People: Memoirs Of A Transplant Surgeon by Thomas Starzl (Author) Given the tensions and demands of medicine, highly successful physicians and surgeons rarely achieve equal success as prose writers. It is truly extraordinary that a major, international pioneer in the controversial field of transplant surgery should have written a spellbinding, and heart-wrenching, autobiography. Thomas Starzl grew up in LeMars, Iowa, the son of a newspaper publisher and a nurse. His father also wrote science fiction and was acquainted with the writer Ray Bradbury. Starzl left the family business to enter Northwestern University Medical School where he earned both and M.D. and a PhD. While he was a student, and later during his surgical internship at the Johns Hopkins Hospital, he began the series of animal experiments that led eventually to the... |
 |
Mind Transplant by Alphonse Mouzon |
 |
Transplant: From Myth to Reality by Dr. Nicholas L. Tilney M.D. (Author) One of the most spectacular medical advances of the twentieth century, organ transplantation has become a generally effective and routine treatment for patients with organ failure. In this riveting book, a well-known expert in the fields of clinical transplantation and transplantation research traces the evolution of organ transplantation from its initial stirrings in the imaginations of the ancients to its current status as accepted treatment for nearly 40,000 patients each year. Drawing often on his own firsthand experience, Dr. Nicholas L. Tilney tells the story of the advances in organ transplantation, discusses how societal forces have driven its development, and reveals how its current success is marred by commercialism and exploitation of the less fortunate. Dr. Tilney describes... |
| © 2009 BrightSurf.com |